Balyasny Asset Management LLC Mannkind Corp Transaction History
Balyasny Asset Management LLC
- $72.4 Billion
- Q3 2025
A detailed history of Balyasny Asset Management LLC transactions in Mannkind Corp stock. As of the latest transaction made, Balyasny Asset Management LLC holds 112,516 shares of MNKD stock, worth $569,330. This represents 0.0% of its overall portfolio holdings.
Number of Shares
112,516
Previous 336,172
66.53%
Holding current value
$569,330
Previous $1.26 Million
51.95%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding MNKD
# of Institutions
260Shares Held
165MCall Options Held
2.76MPut Options Held
689K-
Black Rock Inc. New York, NY22.6MShares$114 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$90.5 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY11.4MShares$57.8 Million1.01% of portfolio
-
State Street Corp Boston, MA10.7MShares$54.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA7.39MShares$37.4 Million0.0% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.3B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...